Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34080452)
Watch
English
Alpha blockers: are all created equal?
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
Alpha blockers: are all created equal?
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
author name string
Debruyne FM
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
language of work or name
English
0 references
publication date
1 November 2000
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
published in
Urology
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
volume
56
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
issue
5 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
page(s)
20-22
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
cites work
Some Clinical Implications of Adrenergic Receptors in the Urinary Tract
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamsulosin : A Review of its Pharmacological Properties and Therapeutic Potential in the Management of Symptomatic Benign Prostatic Hyperplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The concept of uroselectivity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
[Treatment of benign prostatic hyperplasia with alpha 1-adrenoreceptor antagonists]
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900744-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0090-4295(00)00744-5
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
PubMed ID
11074198
1 reference
stated in
Europe PubMed Central
PubMed ID
11074198
retrieved
30 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit